首页> 美国卫生研究院文献>California Medicine >Refractory Sideroblastic and Nonsideroblastic Anemia
【2h】

Refractory Sideroblastic and Nonsideroblastic Anemia

机译:难治性铁粒幼细胞性和非铁粒幼细胞性贫血

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A study was done with 27 patients who met the following criteria: (1) anemia, (2) cellular bone marrow not diagnostic of leukemia, (3) absence of underlying disease that could account for the hematologic abnormalities at time of initial study and (4) absence of iron, B12 or folate deficiency.Of the 27 patients, 13 had ringed sideroblasts and 14 did not. Eleven patients received corticosteroids, 18 received folate, 23 pyridoxine and 12 androgens. Two partial responses occurred in the sideroblastic group and were attributed to androgen therapy in one patient and pyridoxine therapy in the other. In the nonsideroblastic group, two partial responses occurred which were attributed to prednisone therapy. Transfusions were required in 23 patients. Leukemia developed in six patients.It is concluded that currently used treatments have little effect on refractory anemia and that in most patients continuing transfusions are required. In a small percentage of patients, there is transformation to leukemia.
机译:我们对27位符合以下标准的患者进行了研究:(1)贫血;(2)细胞骨髓不能诊断出白血病;(3)缺少可以解释初始研究时血液学异常的基础疾病;和( 4)缺铁,B12或叶酸缺乏。在27例患者中,有13例呈环状铁粒母细胞而14例无。 11例患者接受了皮质类固醇激素治疗,18例患者接受了叶酸,23例吡ido醇和12例雄激素。在铁粒幼细胞组中发生了两个部分反应,其中一个患者归因于雄激素治疗,另一患者归因于吡ido醇治疗。在非铁粒母细胞组中,发生了两个部分反应,这归因于泼尼松治疗。 23名患者需要输血。六名患者发生了白血病。结论是当前使用的治疗对难治性贫血影响不大,并且大多数患者需要持续输血。在少数患者中,有向白血病的转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号